# Study of Rituximab to Treat Chronic Renal Transplant Rejection

> **NCT00476164** · PHASE4 · COMPLETED · sponsor: **King's College London** · enrollment: 62 (actual)

## Conditions studied

- Kidney Transplantation
- Graft Rejection
- Immunosuppression

## Interventions

- **DRUG:** Rituximab
- **OTHER:** Control arm

## Key facts

- **NCT ID:** NCT00476164
- **Lead sponsor:** King's College London
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2015-05
- **Final completion:** 2017-04
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2020-03-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00476164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00476164, "Study of Rituximab to Treat Chronic Renal Transplant Rejection". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00476164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*